The risks of alcohol and other drug consumption to the user are well known, but many Americans–nearly 160 million–say they’ve been harmed by someone else’s substance use, according to a new study in the Journal of Studies on Alcohol and Drugs.
NRx Pharma Subsidiary HOPE Therapeutics Secures $30M to Buy Ketamine Clinics | Psychedelic Invest
HOPE Therapeutics, a subsidiary of Wilmington, Del.-headquartered NRx Pharmaceuticals (Nasdaq: NRXP), has secured a $30 million deal to fund its planned acquisition of a network of psychiatric clinics focused